REALSEQ BIOSCIENCES, INC.
Library preparation kit for single-cell microRNA sequencing using low-input adapter and circularization technology
- Sector
- Biotech
- Headquarters
- Santa Cruz, CA
- Total capital
- $7.5M
- Federal grants
- $7.5M
- 7 awards · 2018–2025
- Rank in peer group#6 of 42
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 9 pending · first 2021
- Rank in peer group#14 of 42
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Preparation of sequencing libraries for multi-analyte analysis of RNAs$1M
- Federal grantHealth and Human S · Phase I · Preparation of sequencing libraries for multi-analyte analysis of small RNAs$300K
- Federal grantHealth and Human S · Phase II · Highly accurate small-RNA sequencing of single cells (RealSeq-SC)$766K
- Federal grantHealth and Human S · Phase II · miR-SEQ: Highly efficient targeted quantification of extracellular miRNAs by Next Generation Sequencing$526K
- Federal grantHealth and Human S · Phase II · Highly accurate small-RNA sequencing of single cells (RealSeq-SC)$2.6M
- Federal grantHealth and Human S · Phase II · miR-SEQ: Highly efficient targeted quantification of extracellular miRNAs by Next Generation Sequencing$255K
- Federal grantHealth and Human S · Phase II · miR-SEQ: Highly efficient targeted quantification of extracellular miRNAs by Next Generation Sequencing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 42 peers
Line = medianBiotech · Instrument
- Federal grants#6 · top 14%
- Granted patents#14 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 3 granted of 12- PendingMethods Of Treating Dimorphic Fungal DiseasesUSPTOApplication 18853311
- GrantedMethods Of Library Construction For Polynucleotide SequencingUSPTOUS 11,964,997
- GrantedMethods Of Constructing Small Rna Libraries And Their Use For Expression Profiling Of Target RnasUSPTOUS 11,072,819
Show all 12 patent records
- Methods Of Treating Dimorphic Fungal DiseasesJul 3, 2025 · Application 18853311Pending
- Methods Of Library Construction For Polynucleotide SequencingApr 23, 2024 · US 11,964,997Granted
- Methods Of Constructing Small Rna Libraries And Their Use For Expression Profiling Of Target RnasJul 27, 2021 · US 11,072,819Granted
- Methods Of Library Construction For Polynucleotide SequencingMay 25, 2021 · US 11,014,957Granted
- Methods Of Library Construction For Target PolynucleotidesDec 20, 2018 · Application 16007769Pending
- Methods Of Library Construction For Target PolynucleotidesApplication 62519371Pending
- Methods Of Preparing Rna Sequencing LibrariesApplication PCTUS2025053370Pending
- Methods Of Library Construction For Polynucleotide SequencingApplication 62270421Pending
- Methods Of Preparing Rna Sequencing LibrariesApplication 63714496Pending
- Methods Of Treating Dimorphic Fungal DiseasesApplication PCTUS2023017726Pending
- Methods Of Treating Dimorphic Fungal DiseasesApplication 63328363Pending
- Methods Of Library Construction For Target PolynucleotidesApplication PCTUS2018037411Pending
Related companies, and why
- Biotherapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- NOARA THERAPEUTICS CORP.Similar federal contract value in Biotech · null in contracts
- CREATIVE BIO-PEPTIDES, INC.Similar federal contract value in Biotech · null in contracts
- CRYPTYX BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
- MAMMAE BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- MS BIOTEC, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .